Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
ProPhase Labs to Present at the 2024 ThinkEquity Conference
-
Westwood Holdings Group, Inc. to Host Third Quarter 2024 Conference Call/Webcast
-
Menlo Micro Announces Global Distribution Agreement with DigiKey to Promote and Deliver Ideal Switch® Products
-
Cayson Acquisition Corp Announces Separate Trading of its Ordinary Shares and Rights
-
Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides difficile infection
-
Annovis to Highlight Buntanetap's Alzheimer's Research Progress with Presentations at CTAD 2024
-
ARMLOGI ENHANCES WAREHOUSE OPERATIONS WITH AI-INTEGRATED WAREHOUSE MANAGEMENT SYSTEM
-
XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist Bioscience
-
Monopar Presents Encouraging Human Clinical Dosimetry Data on its uPAR Program at EANM 2024
-
Janover Unveils Janover Connect: A Reimagined Real Estate Syndication Platform
-
InnovAge to Announce Fiscal First Quarter 2025 Financial Results and Host Conference Call Tuesday, November 5, 2024
-
Gabelli Funds to Host 48th Annual Automotive Symposium at The Encore at Wynn, Las Vegas, Nevada
-
Indaptus Therapeutics Announces Clinical Supply Agreement with BeiGene to Evaluate Novel Cancer Treatment Combinations
-
PDS Biotech Announces Presentation of Rationale and Design of First Recurrent Prostate Cancer Trial to Combine an Androgen Receptor Pathway Inhibitor with an Immunocytokine
-
Huntress Recognized as Inc. 2024 Power Partner for Empowering Small and Mid-Sized Businesses with Cutting-Edge Cybersecurity Protection
-
Blade Air Mobility to Announce Third Quarter 2024 Financial Results on November 12, 2024
-
PodcastOne (PODC) Unveils Explosive 10th Season of The Opportunist: "Tim Ballard: Unmasking a Hero" - Exposing Dark Allegations
-
Guess What? Nobody and Everybody Cares About AI
-
Aligos Therapeutics Announces U.S. FDA Clearance of IND Application for ALG-000184
-
Nukkleus Announces Reverse Stock Split Shares Will Begin Trading on a Split-Adjusted Basis on October 24, 2024
-
Crunchtime Unveils AI Forecasting
-
Arteris to Announce Financial Results for the Third Quarter 2024 on Tuesday, November 5, 2024
-
Reminder: Program for the publication of Yara International ASA third quarter results 2024
-
Allarity Therapeutics to be Granted European Patent for DRP® Companion Diagnostic for Stenoparib
-
ThreatQuotient Unites Cybersecurity Leaders for a Week of In-Depth Threat Intelligence Exploration
-
ZyVersa Therapeutics Highlights Published Data Demonstrating That Obesity Results in Neuroinflammation Implicated in Development of Neurodegenerative Diseases
-
ZyVersa Therapeutics Highlights Published Data Demonstrating That Obesity Results in Neuroinflammation Implicated in Development of Neurodegenerative Diseases
-
Form 8.3 - Learning Technologies Group plc - Octopus Investments
-
SediVision Announces Newly Designed Website to Better Serve Wastewater Industry Professionals
-
BriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival Data
-
Marex Group Plc to Announce Third Quarter 2024 Earnings on November 7, 2024
-
Sify reports Consolidated Financial Results for Q2 FY 2024-25
-
Toobit Leads Conversations on Blockchain Innovation at Future Blockchain Summit 2024
-
Scroll(SCR), a Leading zkRollup Solution, Will Be Initially Listed on CoinW Exchange
-
Keiretsu Forum’s Last Call for the 2024 Investor Capital Expo
-
Old National Bancorp Reports Third Quarter 2024 Results
-
HPQ Files Provisional Patent Application for High Throughput Silicon-Based Anode Material Manufacturing
-
Private capital fees bow to fundraising pressure in 2024 — Preqin reports
-
Lexeo Therapeutics to Present New Interim Data from Phase 1/2 Trial of LX1001 at the Clinical Trials on Alzheimer’s Disease (CTAD) 2024 Conference
-
VR Resources Confirms 50m Base Metal Sulfide Intersection at Silverback Project in Ontario, with Gold Assays Pending
-
Cognition Therapeutics Releases New Episode of “Conversations” Podcast: Executing Clinical Research in Dementia with Lewy Bodies (DLB)
-
BullFrog AI’s VP Artificial Intelligence to Present at Google’s Cancer AI Symposium
-
SIGA Enters into Exclusive License Agreement with Vanderbilt University for Novel Poxvirus Monoclonal Antibodies
-
Dime Community Bancshares, Inc. Reports Third Quarter 2024 Results
-
GURU Organic Energy Achieves Impressive 69% Growth on Amazon Prime Day 2024 Driven by Successful GURU Zero Launch
-
Biogen Announces Late Breaker and New Data Presentations at American Society of Nephrology (ASN) Kidney Week 2024
-
Visionary Financial Expands Global PR Capabilities with Acquisition of The PR Builder, an AI Press Release Generator and Distribution Platform
-
Gradient Denervation Technologies Appoints Stanton Rowe to Board of Directors and Receives FDA Approval to Expand Early Feasibility Study
-
Clearside Biomedical’s Positive ODYSSEY Wet AMD Data and Suprachoroidal Injection Platform Highlighted in Presentations at Multiple Events During AAO 2024 Annual Meeting
-
Lithium Ionic Initiates Engineering and Construction Management Services Contracts, Awarded to Hatch and Reta for Bandeira Project Development
